FK506是一种新型免疫抑制剂。
谷氨酸有希望成为一种低毒有效的免疫抑制剂。
These drugs will become low toxic effective immunosuppressive agents in the future.
结论免疫抑制剂的应用是治疗老年MG的重要措施。
Conclusions Immunosuppressive treatments should be still an important therapeutic measure in the aged MG patients.
他克莫司是一种用于器官移植患者的重要免疫抑制剂。
Tacrolimus is an important immunosuppressive drug for organ transplantation patients.
目的：研究动态监测免疫抑制剂fk506的临床意义。
Objective: to study dynamic monitoring FK506 and it's clinical value.
结论利用新型免疫抑制剂获得了异体手移植的早期成功。
Conclusions Early success has been achieved in hand transplantation with the use of currently available immunosuppressive drugs.
非甾类抗炎药加用激素甚至免疫抑制剂是常用的治疗方法。
Non-steroid anti-inflammatory drugs plus hormone or even immunosuppressor were common measures of treatment.
免疫抑制过度及时减量或停用免疫抑制剂，加用丙种球蛋白。
Immunosuppressant should be reduced or withdrawn and gamma globulin be added when excess immunologic suppression occurs.
两次排斥事件的结局均良好，容许医生减少免疫抑制剂的用量。
Both rejection episodes resulted in favorable outcomes, allowing doctors to reduce the immunosuppressive treatment regimen.
在加强抗生素治疗的同时还应调整免疫抑制剂和加强营养支持。
Immunosuppressive regimen should be adjusted and nutritional support enhanced on the basis of fortified antibiotic therapy.
血浆置换和激素免疫抑制剂无效病例，可考t - V双肾切除。
The blood plasma replacement and the hormone immunity inhibitor invalid case, may test the tV double kidney excision.
蛋白尿症与肾小球的病变以及西罗莫司(免疫抑制剂)的使用相关。
Proteinuria was associated with the presence of graft glomerular pathology and the use of sirolimus.
这例病人的炎性关节炎要求她接受免疫抑制剂治疗，以控制其症状。
This patient's inflammatory arthritis required that she receive immunosuppressive therapy to control her symptoms.
免疫抑制剂fk506的加入对导管材料的降解性能有一定的影响。
To the degradation characteristics of conduits, the immunosuppressive agent FK506 had definite influence.
目的对比观察传统与新型免疫抑制剂对自身免疫性甲状腺眼病的疗效。
Objective to compare the curative effects between the traditional and new immunosuppressants in autoimmune thyroid ophthalmopathy.
早期诊断并给予糖皮质激素治疗有效，部分患者尚须加用免疫抑制剂。
Early diagnosis and treatment with glucocorticoid and immunosuppressive agents can improve the prognosis obviously.
免疫抑制剂FK506的双重作用在神经再生治疗中具广阔的应用前景。
The double role of immunosuppressive agent FK506 may have broad application prospect in treatment of nerve regeneration.
目的：综述雷公藤作为免疫抑制剂在临床上的毒副反应及临床减毒方法。
Objective: to review Tripterygium Wifordii as immunosuppressant in the clinical toxicity and clinical attenuated method.
一份2007年的分析指出，许多病人理解要在余生服用免疫抑制剂的必要性。
One 2007 analysis states that many patients understand the need to take immunosuppressant drugs for the remainder of their lives.
免疫抑制剂抑制所有的T细胞或T细胞亚群，引起免疫系统的非特异性抑制。
Immunosuppressive agents inhibit all t cell or subset of t cells and cause nonspecific suppression of the immune system.
禁用于老年、婴幼儿、孕妇和患有严重慢性幕础疾患或接受免疫抑制剂治疗者。
Is forbid in the old age, the babies and infants, the pregnant woman and contracts the serious chronic curtain foundation illness trouble or accepts the immunity inhibitor curer.
结果：辅助性肝脏移植患者免疫抑制剂浓度相对较低，排斥反应次数少，强度低。
Results:Immunosuppressive agent concentration was lower, rejection was less and intensity was milder in these patients.
结论免疫抑制剂fk506能促进外周神经端-侧吻合后神经再生的速度和质量。
Conclusion Immunosuppresssant FK506 could promote nerve regenerative speed and quality after end-to-side neurorrhaphy of peripheral nerve.
免疫抑制剂FK506能有效地抑制周围神经同种异体和异种移植中的排斥反应。
FK506 can suppress the rejection of xenoma and xenograft effectively in the peripheral nerve.
此外，病人可能有肺部感染，特别是在病人正接受免疫抑制剂治疗其基础性风湿病。
In addition she may have a pulmonary infection particularly if she is receiving immunosuppressive therapy for her underlying rheumatic disease.
免疫抑制剂治疗，如利妥昔单抗，硫唑嘌呤和环磷酰胺，明显减少抗体水平和复发率。
Treatment with immunosuppressants such as rituximab, azathioprine and cyclophosphamide resulted in a marked reduction in antibody levels and relapse rates.
这可能已发生的，因为一个障碍在他们的免疫系统，或因为他们已治疗与免疫抑制剂。
This may have occurred because of a disorder in their immune system, or because they have had treatment with immunosuppressive drugs.
塔伯曼医生说，“我们给他们开一些药效非常强的药剂和免疫抑制剂来抑制排异反应。”
Teperman said. "we give them very strong, high-powered medications, immunosuppressants, to prevent rejection."
结论胰肾联合移植围手术期并发症的处理是管理的重点，应注意免疫抑制剂的个体化。
Conclusion Control of perioperative complications is the focal point of SPK transplantation, and the dosage of immunosuppressive agents must be adjusted individually.
结论胰肾联合移植围手术期并发症的处理是管理的重点，应注意免疫抑制剂的个体化。
Conclusion Control of perioperative complications is the focal point of SPK transplantation, and the dosage of immunosuppressive agents must be adjusted individually.
应用推荐